Compass Therapeutics (NASDAQ:CMPX – Get Free Report) and HilleVax (NASDAQ:HLVX – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, risk, earnings, institutional ownership, analyst recommendations and valuation. Institutional and Insider Ownership 68.4% of Compass Therapeutics […]
Foresite Capital Management V LLC cut its holdings in Compass Therapeutics, Inc. (NASDAQ:CMPX – Free Report) by 5.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,246,977 shares of the company’s stock after selling 77,094 shares during the period. Compass Therapeutics […]
Foresite Capital Management V LLC lowered its stake in shares of Compass Therapeutics, Inc. (NASDAQ:CMPX – Free Report) by 5.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,246,977 shares of the company’s stock after selling 77,094 shares during the quarter. […]
Compass Therapeutics, Inc. (NASDAQ:CMPX – Get Free Report) saw a significant drop in short interest in January. As of January 15th, there was short interest totalling 1,980,000 shares, a drop of 12.8% from the December 31st total of 2,270,000 shares. Based on an average trading volume of 511,500 shares, the short-interest ratio is currently 3.9 […]
Compass Therapeutics, Inc. (NASDAQ:CMPX – Get Free Report) was the recipient of a significant decline in short interest during the month of November. As of November 30th, there was short interest totalling 2,670,000 shares, a decline of 10.1% from the November 15th total of 2,970,000 shares. Based on an average trading volume of 312,500 shares, […]